title: A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation.
abstract: Obesity causes increased classical and decreased alternative macrophage activation, which in turn cause insulin resistance in target organs. Because A2B adenosine receptors (ARs) are important regulators of macrophage activation, we examined the role of A2B ARs in adipose tissue inflammation and insulin resistance. A2B AR deletion impaired glucose and lipid metabolism in mice fed chow but not a high-fat diet, which was paralleled by dysregulation of the adipokine system, and increased classical macrophage activation and inhibited alternative macrophage activation. The expression of alternative macrophage activation-specific transcriptions factors, including CCAAT/enhancer-binding protein-β, interferon regulatory factor 4, and peroxisome proliferator-activated receptor-γ, was decreased in adipose tissue of A2B AR-deficient mice. Furthermore, in in vitro studies, we found that stimulation of A2B ARs suppressed free fatty acid-induced deleterious inflammatory and metabolic activation of macrophages. Moreover, AR activation upregulated the interleukin-4-induced expression of CCAAT/enhancer-binding protein-β, interferon regulatory factor 4, and peroxisome proliferator-activated receptor-γ in macrophages. Altogether, our results indicate that therapeutic strategies targeting A2B ARs hold promise for preventing adipose tissue inflammation and insulin resistance.
authors.affiliation: Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ.
authors.forename: Balázs
authors.initials: B
authors.lastname: Csóka
authors.forename: Balázs
authors.initials: B
authors.lastname: Koscsó
authors.forename: Gábor
authors.initials: G
authors.lastname: Töro
authors.forename: Endre
authors.initials: E
authors.lastname: Kókai
authors.forename: László
authors.initials: L
authors.lastname: Virág
authors.forename: Zoltán H
authors.initials: ZH
authors.lastname: Németh
authors.forename: Pál
authors.initials: P
authors.lastname: Pacher
authors.forename: Péter
authors.initials: P
authors.lastname: Bai
authors.forename: György
authors.initials: G
authors.lastname: Haskó
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D000273:Adipose Tissue / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000502:physiology; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006706:Homeostasis; D007249:Inflammation / Q000517:prevention & control*; D007333:Insulin Resistance; D008262:Macrophage Activation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D047495:PPAR gamma / Q000502:physiology; D043704:Receptor, Adenosine A2B / Q000502:physiology*; D014280:Triglycerides / Q000378:metabolism
chemical_list: D022782:CCAAT-Enhancer-Binding Protein-beta; D047495:PPAR gamma; D043704:Receptor, Adenosine A2B; D014280:Triglycerides; D002784:Cholesterol; D005947:Glucose; D000241:Adenosine